Skeletal muscle mitochondrial dysfunction during chronic obstructive pulmonary disease: Central actor and therapeutic target

Experimental Physiology

Volumn 98, Issue 6, 2013, Pages 1063-1078

  Meyer, Alain ^a,b   Zoll, Joffrey ^a,b   Charles, Anne Laure ^a   Charloux, Anne ^a,b   de Blay, Frédéric ^a,b   Diemunsch, Pierre ^a,c   Sibilia, Jean ^b   Piquard, François ^a,b   Geny, Bernard ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c Service d'Anesthésie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CORTICOSTEROID; REACTIVE OXYGEN METABOLITE;

BIOGENESIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; EXERCISE; EXERCISE TOLERANCE; HUMAN; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MUSCLE FUNCTION; NONHUMAN; OXIDATIVE STRESS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY CHAIN; REVIEW; SKELETAL MUSCLE;

EID: 84878150850     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2012.069468     Document Type: Review

References (148)

1. Agustí AGN, Sauleda J, Miralles C, Gomez C, Togores B, Sala E, Batle S & Busquets X (2002). Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166, 485-489.
2. Allaire J, Maltais F, Doyon JF, Noël M, LeBlanc P, Carrier G, Simard C & Jobin J (2004). Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax 59, 673-678.
3. Allaire J, Maltais F, LeBlanc P, Simard PM, Whittom F, Doyon JF, Simard C & Jobin J (2002). Lipofuscin accumulation in the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Muscle Nerve 25, 383-389.
4. Alonso JR, Cardellach F, López S, Casademont J & Miró O (2003). Carbon monoxide specifically inhibits cytochrome c oxidase of human mitochondrial respiratory chain. Pharmacol Toxicol 93, 142-146.
5. Ansari K, Keaney N, Taylor I, Burns G & Farrow M (2012). Muscle weakness, health status and frequency of exacerbations in chronic obstructive pulmonary disease. Postgrad Med J 88, 372-376.
6. Barreiro E, de la Puente B, Minguella J, Corominas JM, Serrano S, Hussain SNA & Gea J (2005). Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171, 1116-1124.
7. Barreiro E, Ferrer D, Sanchez F, Minguella J, Marin-Corral J, Martinez-Llorens J, Lloreta J & Gea J (2011). Inflammatory cells and apoptosis in respiratory and limb muscles of patients with COPD. J Appl Physiol 111, 808-817.
8. Barreiro E, Gea J, Corominas JM & Hussain SN (2003). Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 29, 771-778.
9. Barreiro E, Rabinovich R, Marin-Corral J, Barberà JA, Gea J & Roca J (2009). Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD. Thorax 64, 13-19.
10. Barreiro E, Schols AMWJ, Polkey MI, Galdiz JB, Gosker HR, Swallow EB, Coronell C & Gea J (2008). Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax 63, 100-107.
11. Bartlett J, Brunner M & Gough K (2010). Deliberate poisoning with dinitrophenol (DNP): an unlicensed weight loss pill. Emerg Med J 27, 159-160.
12. Bernard S, LeBlanc P, Whittom F, Carrier G, Jobin J, Belleau R & Maltais F (1998). Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158, 629-634.
13. Blier PU & Lemieux H (2001). The impact of the thermal sensitivity of cytochrome c oxidase on the respiration rate of Arctic charr red muscle mitochondria. J Comp Physiol B 171, 247-253.
14. Bouitbir J, Charles AL, Echaniz-Laguna A, Kindo M, Daussin F, Auwerx J, Piquard F, Geny B & Zoll J (2012). Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a 'mitohormesis' mechanism involving reactive oxygen species and PGC-1. Eur Heart J 33, 1397-1407.
15. Brand MD, Pamplona R, Portero-Otín M, Requena JR, Roebuck SJ, Buckingham JA, Clapham JC & Cadenas S (2002). Oxidative damage and phospholipid fatty acyl composition in skeletal muscle mitochondria from mice underexpressing or overexpressing uncoupling protein 3. Biochem J 368, 597-603.
16. Broekhuizen R, Wouters EFM, Creutzberg EC, Weling-Scheepers CA & Schols AMWJ (2005). Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease. Thorax 60, 376-382.
17. Cardellach F, Alonso JR, López S, Casademont J & Miró O (2003). Effect of smoking cessation on mitochondrial respiratory chain function. J Toxicol Clin Toxicol 41, 223-228.
18. Chance B & Williams GR (1955). Respiratory enzymes in oxidative phosphorylation. III. The steady state. J Biol Chem 217, 409-427.
19. Charles AL, Guilbert AS, Bouitbir J, Goette-Di Marco P, Enache I, Zoll J, Piquard F & Geny B (2011). Effect of postconditioning on mitochondrial dysfunction in experimental aortic cross-clamping. Br J Surg 98, 511-516.
20. Couillard A, Koechlin C, Cristol JP, Varray A & Prefaut C (2002). Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients. Eur Respir J 20, 1123-1129.
21. Couillard A, Maltais F, Saey D, Debigaré R, Michaud A, Koechlin C, LeBlanc P & Préfaut C (2003). Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167, 1664-1669.
22. Couillard A & Prefaut C (2005). From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Respir J 26, 703-719.
23. Cuttica MJ, Shah SJ, Rosenberg SR, Orr R, Beussink L, Dematte JE, Smith LJ & Kalhan R (2011). Right heart structural changes are independently associated with exercise capacity in non-severe COPD. PLoS One 6, e29069.
24. Decramer M, De Bock V & Dom R (1996). Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 153, 1958-1964.
25. Decramer M, Janssens W & Miravitlles M (2012). Chronic obstructive pulmonary disease. Lancet 379, 1341-1351.
26. De Larichaudy J, Zufferli A, Serra F, Isidori AM, Naro F, Dessalle K, Desgeorges M, Piraud M, Cheillan D, Vidal H, Lefai E & Némoz G (2012). TNF-α- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism. Skelet Muscle 2, 2.
27. de Theije C, Costes F, Langen RCJ, Pison C & Gosker HR (2011). Hypoxia and muscle maintenance regulation: implications for chronic respiratory disease. Curr Opin Clin Nutr Metab Care 14, 548-553.
28. Duclos M, Gouarne C, Martin C, Rocher C, Mormède P & Letellier T (2004). Effects of corticosterone on muscle mitochondria identifying different sensitivity to glucocorticoids in Lewis and Fischer rats. Am J Physiol Endocrinol Metab 286, E159-E167.
29. Duteil D, Chambon C, Ali F, Malivindi R, Zoll J, Kato S, Geny B, Chambon P & Metzger D (2010). The transcriptional coregulators TIF2 and SRC-1 regulate energy homeostasis by modulating mitochondrial respiration in skeletal muscles. Cell Metab 12, 496-508.
30. Eliason G, Abdel-Halim SM, Piehl-Aulin K & Kadi F (2010). Alterations in the muscle-to-capillary interface in patients with different degrees of chronic obstructive pulmonary disease. Respir Res 11, 97.
31. Engelen MPKJ, Schols AMWJ, Baken WC, Wesseling GJ & Wouters EFM (1994). Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J 7, 1793-1797.
32. Engelen MPKJ, Schols AMWJ, Does JD & Wouters EFM (2000). Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 71, 733-738.
33. Fermoselle C, Rabinovich R, Ausín P, Puig-Vilanova E, Coronell C, Sanchez F, Roca J, Gea J & Barreiro E (2012). Does oxidative stress modulate limb muscle atrophy in severe COPD patients Eur Respir J 40, 851-862.
34. Fiaccadori E, Del Canale S, Vitali P, Coffrini E, Ronda N & Guariglia A (1987). Skeletal muscle energetics, acid-base equilibrium and lactate metabolism in patients with severe hypercapnia and hypoxia. Chest 92, 883-887.
35. Figueiredo PA, Powers SK, Ferreira RM, Amado F, Appell HJ & Duarte JA (2009). Impact of lifelong sedentary behavior on mitochondrial function of mice skeletal muscle. J Gerontol A Biol Sci Med Sci 64, 927-939.
36. Formenti F, Constantin-Teodosiu D, Emmanuel Y, Cheeseman J, Dorrington KL, Edwards LM, Humphreys SM, Lappin TRJ, McMullin MF, McNamara CJ, Mills W, Murphy JA, O'Connor DF, Percy MJ, Ratcliffe PJ, Smith TG, Treacy M, Frayn KN, Greenhaff PL, Karpe F, Clarke K & Robbins PA (2010). Regulation of human metabolism by hypoxia-inducible factor. Proc Natl Acad Sci U S A 107, 12722-12727.
37. Franssen FME, Broekhuizen R, Janssen PP, Wouters EFM & Schols AMWJ (2004). Effects of whole-body exercise training on body composition and functional capacity in normal-weight patients with COPD. Chest 125, 2021-2028.
38. Gamboa JL & Andrade FH (2012). Muscle endurance and mitochondrial function after chronic normobaric hypoxia: contrast of respiratory and limb muscles. Pflugers Arch 463, 327-338.
39. Gea JG, Pasto M, Carmona MA, Orozco-Levi M, Palomeque J & Broquetas J (2001). Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. Eur Respir J 17, 939-945.
40. Geny B, Saini J, Mettauer B, Lampert E, Piquard F, Follenius M, Epailly E, Schnedecker B, Eisenmann B, Haberey P & Lonsdorfer J (1996). Effect of short-term endurance training on exercise capacity, haemodynamics and atrial natriuretic peptide secretion in heart transplant recipients. Eur J Appl Physiol Occup Physiol 73, 259-266.
41. Gertz I, Hedenstierna G, Hellers G & Wahren J (1977). Muscle metabolism in patients with chronic obstructive lung disease and acute respiratory failure. Clin Sci Mol Med 52, 396-403.
42. Gosker HR, Bast A, Haenen GR, Fischer MA, van der Vusse GJ, Wouters EFM & Schols AMWJ (2005). Altered antioxidant status in peripheral skeletal muscle of patients with COPD. Respir Med 99, 118-125.
43. Gosker HR, Hesselink MKC, Duimel H, Ward KA & Schols AMWJ (2007). Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD. Eur Respir J 30, 73-79.
44. Gosker HR, Kubat B, Schaart G, Van Der Vusse GJ, Wouters EFM & Schols AMWJ (2003a). Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease. Eur Respir J 22, 280-285.
45. Gosker HR, Schrauwen P, Broekhuizen R, Hesselink MK, Moonen-Kornips E, Ward KA, Franssen FME, Wouters EFM & Schols AMWJ (2006). Exercise training restores uncoupling protein-3 content in limb muscles of patients with chronic obstructive pulmonary disease. Am J Physiol Endocrinol Metab 290, E976-E981.
46. Gosker HR, Schrauwen P, Hesselink MKC, Schaart G, Van Der Vusse GJ, Wouters EFM & Schols AMWJ (2003b). Uncoupling protein-3 content is decreased in peripheral skeletal muscle of patients with COPD. Eur Respir J 22, 88-93.
47. Gosker HR, van Mameren H, van Dijk PJ, Engelen MP, van der Vusse GJ, Wouters EFM & Schols AMWJ (2002). Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J 19, 617-625.
48. Gosselink R, Troosters T & Decramer M (1996). Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 153, 976-980.
49. Gosselink R, Troosters T & Decramer M (2000). Distribution of muscle weakness in patients with stable chronic obstructive pulmonary disease. J Cardiopulm Rehabil 20, 353-360.
50. Gouzi F, Préfaut C, Abdellaoui A, Roudier E, de Rigal P, Molinari N, Laoudj-Chenivesse D, Mercier J, Birot O & Hayot M (2012). Blunted muscle angiogenic training-response in copd patients versus sedentary controls. Eur Respir J, doi: 10.1183/09031936.00053512.
51. Guo BS, Cheung KK, Yeung SS, Zhang BT & Yeung EW (2012). Electrical stimulation influences satellite cell proliferation and apoptosis in unloading-induced muscle atrophy in mice. PLoS One 7, e30348.
52. Gvozdjáková A, Kucharská J & Gvozdják J (1992). Effect of smoking on the oxidative processes of cardiomyocytes. Cardiology 81, 81-84.
53. Hamilton AL, Killian KJ, Summers E & Jones NL (1995). Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 152, 2021-2023.
54. Hardin BJ, Campbell KS, Smith JD, Arbogast S, Smith J, Moylan JS & Reid MB (2008). TNF-α acts via TNFR1 and muscle-derived oxidants to depress myofibrillar force in murine skeletal muscle. J Appl Physiol 104, 694-699.
55. Himms-Hagen J & Harper ME (2001). Physiological role of UCP3 may be export of fatty acids from mitochondria when fatty acid oxidation predominates: an hypothesis. Exp Biol Med (Maywood) 226, 78-84.
56. Howald H, Hoppeler H, Claassen H, Mathieu O & Straub R (1985). Influences of endurance training on the ultrastructural composition of the different muscle fiber types in humans. Pflugers Arch 403, 369-376.
57. Jakobsson P, Jorfeldt L & Henriksson J (1995). Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 151, 374-377.
58. Jatta K, Eliason G, Portela-Gomes GM, Grimelius L, Caro O, Nilholm L, Sirjsö A, Piehl-Aulin K & Abdel-Halim SM (2009). Overexpression of von Hippel-Lindau protein in skeletal muscles of patients with chronic obstructive pulmonary disease. J Clin Pathol 62, 70-76.
59. Jobin J, Maltais F, Doyon JF, LeBlanc P, Simard PM, Simard AA & Simard C (1998). Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. J Cardiopulm Rehabil 18, 432-437.
60. Johnson MA, Polgar J, Weightman D & Appleton D (1973). Data on the distribution of fibre types in thirty-six human muscles. An autopsy study. J Neurol Sci 18, 111-129.
61. Jones NL & Killian KJ (1991). Limitation of exercise in chronic pulmonary disease. In Chronic Obstructive Pulmonary Disease, ed. Cherniack NS, pp. 196-206. W.B. Saunders, Philadelphia .
62. Joseph AM, Adhihetty PJ, Buford TW, Wohlgemuth SE, Lees HA, Nguyen LM, Aranda JM, Sandesara BD, Pahor M, Manini TM, Marzetti E & Leeuwenburgh C (2012). The impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary high- and low-functioning elderly individuals. Aging Cell 11, 801-809.
63. L. Cell Death Differ 17, 1420-1434.
64. Koechlin C, Couillard A, Simar D, Cristol JP, Bellet H, Hayot M & Prefaut C (2004). Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease Am J Respir Crit Care Med 169, 1022-1027.
65. Koechlin C, Maltais F, Saey D, Michaud A, LeBlanc P, Hayot M & Préfaut C (2005). Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease. Thorax 60, 834-841.
66. Koerts-de Lang E, Hesselink MK, Drost MR, van der Vusse GJ, Wouters EFM & Schols AMWJ (1999). Enzyme activity of rat tibialis anterior muscle differs between treatment with triamcinolone and prednisolone and nutritional deprivation. Eur J Appl Physiol Occup Physiol 79, 274-279.
67. Kok MO, Hoekstra T & Twisk JW (2012). The longitudinal relation between smoking and muscle strength in healthy adults. Eur Addict Res 18, 70-75.
68. Lacasse Y, Guyatt GH & Goldstein RS (1997). The components of a respiratory rehabilitation program: a systematic overview. Chest 111, 1077-1088.
69. Lacerda L, McCarthy J, Mungly SF, Lynn EG, Sack MN, Opie LH & Lecour S (2010). TNFα protects cardiac mitochondria independently of its cell surface receptors. Basic Res Cardiol 105, 751-762.
70. Lands LC, Smountas AA, Mesiano G, Brosseau L, Shennib H, Charbonneau M & Gauthier R (1999). Maximal exercise capacity and peripheral skeletal muscle function following lung transplantation. J Heart Lung Transplant 18, 113-120.
71. Larsen RG, Callahan DM, Foulis SA & Kent-Braun JA (2009). In vivo oxidative capacity varies with muscle and training status in young adults. J Appl Physiol 107, 873-879.
72. Larsen S, Nielsen J, Hansen CN, Nielsen LB, Wibrand F, Stride N, Schroder HD, Boushel R, Helge JW, Dela F & Hey-Mogensen M (2012). Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects. J Physiol 590, 3349-3360.
73. Levett DZ, Radford EJ, Menassa DA, Graber EF, Morash AJ, Hoppeler H, Clarke K, Martin DS, Ferguson-Smith AC, Montgomery HE, Grocott MPW & Murray AJ; Caudwell Xtreme Everest Research Group (2012). Acclimatization of skeletal muscle mitochondria to high-altitude hypoxia during an ascent of Everest. FASEB J 26, 1431-1441.
74. Lundby C, Calbet JAL & Robach P (2009). The response of human skeletal muscle tissue to hypoxia. Cell Mol Life Sci 66, 3615-3623.
75. MacIntyre NR (2000). Oxygen therapy and exercise response in lung disease. Respir Care 45, 194-200.
76. MacNee W & Rahman I (1999). Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160, S58-S65.
77. Mador MJ (2002). Muscle mass, not body weight, predicts outcome in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166, 787-789.
78. Maltais F, LeBlanc P, Simard C, Jobin J, Bérubé C, Bruneau J, Carrier L & Belleau R (1996a). Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154, 442-447.
79. Maltais F, LeBlanc P, Whittom F, Simard C, Marquis K, Bélanger M, Breton MJ & Jobin J (2000). Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax 55, 848-853.
80. Maltais F, Simard AA, Simard C, Jobin J, Desgagnés P & LeBlanc P (1996b). Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 153, 288-293.
81. Marquis K, Debigaré R, Lacasse Y, LeBlanc P, Jobin J, Carrier G & Maltais F (2002). Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166, 809-813.
82. Martens ME, Peterson PL & Lee CP (1991). In vitro effects of glucocorticoid on mitochondrial energy metabolism. Biochim Biophys Acta 1058, 152-160.
83. Martinelli M, Winterhalder R, Cerretelli P, Howald H & Hoppeler H (1990). Muscle lipofuscin content and satellite cell volume is increased after high altitude exposure in humans. Experientia 46, 672-676.
84. Mason SD, Howlett RA, Kim MJ, Olfert IM, Hogan MC, McNulty W, Hickey RP, Wagner PD, Kahn CR, Giordano FJ & Johnson RS (2004). Loss of skeletal muscle HIF-1α results in altered exercise endurance. PLoS Biol 2, e288.
85. Menon MK, Houchen L, Singh SJ, Morgan MD, Bradding P & Steiner MC (2012). Inflammatory and satellite cells in the quadriceps of patients with COPD and the response to resistance training. Chest 142, 1134-1142.
86. Montes de Oca M, Loeb E, Torres SH, De Sanctis J, Hernández N & Tálamo C (2008). Peripheral muscle alterations in non-COPD smokers. Chest 133, 13-18.
87. Montes de Oca M, Torres SH, De Sanctis J, Mata A, Hernández N & Tálamo C (2005). Skeletal muscle inflammation and nitric oxide in patients with COPD. Eur Respir J 26, 390-397.
88. Murphy BJ, Robin ED, Tapper DP, Wong RJ & Clayton DA (1984). Hypoxic coordinate regulation of mitochondrial enzymes in mammalian cells. Science 223, 707-709.
89. Naimi AI, Bourbeau J, Perrault H, Baril J, Wright-Paradis C, Rossi A, Taivassalo T, Sheel AW, Rabøl R, Dela F & Boushel R (2011). Altered mitochondrial regulation in quadriceps muscles of patients with COPD. Clin Physiol Funct Imaging 31, 124-131.
90. Nioka S, Argov Z, Dobson GP, Forster RE, Subramanian HV, Veech RL & Chance B (1992). Substrate regulation of mitochondrial oxidative phosphorylation in hypercapnic rabbit muscle. J Appl Physiol 72, 521-528.
91. Picard M, Godin R, Sinnreich M, Baril J, Bourbeau J, Perrault H, Taivassalo T & Burelle Y (2008). The mitochondrial phenotype of peripheral muscle in chronic obstructive pulmonary disease: disuse or dysfunction Am J Respir Crit Care Med 178, 1040-1047.
92. Pinto-Plata VM, Müllerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS & Celli BR (2006). C-Reactive protein in patients with COPD, control smokers and non-smokers. Thorax 61, 23-28.
93. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M & Gosselink R (2005). Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171, 972-977.
94. Pouw EM, Koerts-de Lang E, Gosker HR, Freling G, van der Vusse GJ, Wouters EFM & Schols AMWJ (2000). Muscle metabolic status in patients with severe COPD with and without long-term prednisolone. Eur Respir J 16, 247-252.
95. Powers SK, Wiggs MP, Duarte JA, Zergeroglu AM & Demirel HA (2012). Mitochondrial signaling contributes to disuse muscle atrophy. Am J Physiol Endocrinol Metab 303, E31-E39.
96. 2α-III, an index of oxidant stress. Am J Respir Crit Care Med 158, 1709-1714.
97. Puente-Maestu L, Lázaro A, Tejedor A, Camaño S, Fuentes M, Cuervo M, Navarro BO & Agustí A (2011). Effects of exercise on mitochondrial DNA content in skeletal muscle of patients with COPD. Thorax 66, 121-127.
98. Puente-Maestu L, Pérez-Parra J, Godoy R, Moreno N, Tejedor A, González-Aragoneses F, Bravo JL, Alvarez FV, Camaño S & Agustí A (2009a). Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients. Eur Respir J 33, 1045-1052.
99. Puente-Maestu L, Pérez-Parra J, Godoy R, Moreno N, Tejedor A, Torres A, Lázaro A, Ferreira A & Agustí A (2009b). Abnormal transition pore kinetics and cytochrome c release in muscle mitochondria of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 40, 746-750.
100. Puente-Maestu L, Tejedor A, Lázaro A, de Miguel J, Alvarez-Sala L, González-Aragoneses F, Simón C & Agustí A (2012). Site of mitochondrial ROS production in skeletal muscle of COPD and its relationship with exercise oxidative stress. Am J Respir Cell Mol Biol 47, 358-362.
101. Puente-Maestu L, Tena T, Trascasa C, Pérez-Parra J, Godoy R, García MJ & Stringer WW (2003). Training improves muscle oxidative capacity and oxygenation recovery kinetics in patients with chronic obstructive pulmonary disease. Eur J Appl Physiol 88, 580-587.
102. Rabinovich RA, Ardite E, Mayer AM, Polo MF, Vilaró J, Argilés JM & Roca J (2006). Training depletes muscle glutathione in patients with chronic obstructive pulmonary disease and low body mass index. Respiration 73, 757-761.
103. Rabinovich RA, Ardite E, Troosters T, Carbó N, Alonso J, Gonzalez de Suso JM, Vilaró J, Barberà JA, Polo MF, Argilés JM, Fernandez-Checa JC & Roca J (2001). Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164, 1114-1118.
104. Rabinovich RA, Bastos R, Ardite E, Llinàs L, Orozco-Levi M, Gea J, Vilaró J, Barberà JA, Rodríguez-Roisin R, Fernández-Checa JC & Roca J (2007). Mitochondrial dysfunction in COPD patients with low body mass index. Eur Respir J 29, 643-650.
105. Rabinovich RA, Figueras M, Ardite E, Carbó N, Troosters T, Filella X, Barberà JA, Fernandez-Checa JC, Argilés JM & Roca J (2003). Increased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patients. Eur Respir J 21, 789-794.
106. Rabinovich RA & Vilaró J (2010). Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 16, 123-133.
107. Radom-Aizik S, Kaminski N, Hayek S, Halkin H, Cooper DM & Ben-Dov I (2007). Effects of exercise training on quadriceps muscle gene expression in chronic obstructive pulmonary disease. J Appl Physiol 102, 1976-1984.
108. Rahman I, Skwarska E & MacNee W (1997). Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax 52, 565-568.
109. Reid MB, Lännergren J & Westerblad H (2002). Respiratory and limb muscle weakness induced by tumor necrosis factor-α: involvement of muscle myofilaments. Am J Respir Crit Care Med 166, 479-484.
110. Remels AHV, Gosker HR, Schrauwen P, Hommelberg PPH, Sliwinski P, Polkey M, Galdiz J, Wouters EFM, Langen RCJ & Schols AMWJ (2010). TNF-α impairs regulation of muscle oxidative phenotype: implications for cachexia FASEB J 24, 5052-5062.
111. Remels AHV, Gosker HR, Schrauwen P, Langen RCJ & Schols AMWJ (2008). Peroxisome proliferator-activated receptors: a therapeutic target in COPD Eur Respir J 31, 502-508.
112. Remels AHV, Schrauwen P, Broekhuizen R, Willems J, Kersten S, Gosker HR & Schols AMWJ (2007). Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD. Eur Respir J 30, 245-252.
113. Rouyer O, Zoll J, Daussin F, Damgé C, Helms P, Talha S, Rasseneur L, Piquard F & Geny B (2007). Effect of angiotensin-converting enzyme inhibition on skeletal muscle oxidative function and exercise capacity in streptozotocin-induced diabetic rats. Exp Physiol 92, 1047-1056.
114. Russell AP, Feilchenfeldt J, Schreiber S, Praz M, Crettenand A, Gobelet C, Meier CA, Bell DR, Kralli A, Giacobino JP & Dériaz O (2003). Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-γ coactivator-1 and peroxisome proliferator-activated receptor-α in skeletal muscle. Diabetes 52, 2874-2881.
115. Russell AP, Somm E, Debigaré R, Hartley O, Richard D, Gastaldi G, Melotti A, Michaud A, Giacobino JP, Muzzin P, LeBlanc P & Maltais F (2004). COPD results in a reduction in UCP3 long mRNA and UCP3 protein content in types I and IIa skeletal muscle fibers. J Cardiopulm Rehabil 24, 332-339.
116. Saey D, Debigare R, LeBlanc P, Mador MJ, Cote CH, Jobin J & Maltais F (2003). Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 168, 425-430.
117. Safdar A, Hamadeh MJ, Kaczor JJ, Raha S, Debeer J & Tarnopolsky MA (2010). Aberrant mitochondrial homeostasis in the skeletal muscle of sedentary older adults. PLoS One 5, e10778.
118. Sandri M (2002). Apoptotic signaling in skeletal muscle fibers during atrophy. Curr Opin Clin Nutr Metab Care 5, 249-253.
119. Sandri M, Lin J, Handschin C, Yang W, Arany ZP, Lecker SH, Goldberg AL & Spiegelman BM (2006). PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci U S A 103, 16260-16265.
120. Sauleda J, García-Palmer F, Wiesner RJ, Tarraga S, Harting I, Tomás P, Gómez C, Saus C, Palou A & Agustí AGN (1998). Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157, 1413-1417.
121. Schols AMWJ, Broekhuizen R, Weling-Scheepers CA & Wouters EF (2005). Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 82, 53-59.
122. Schols AMWJ, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ & Wouters EFM (1993). Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 147, 1151-1156.
123. Schrauwen P, Saris WH & Hesselink MK (2001). An alternative function for human uncoupling protein 3: protection of mitochondria against accumulation of nonesterified fatty acids inside the mitochondrial matrix. FASEB J 15, 2497-2502.
124. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA & Fiers W (1992). Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 267, 5317-5323.
125. Sin DD & Man SF (2006). Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link Thorax 61, 1-3.
126. Song XM, Kawano Y, Krook A, Ryder JW, Efendic S, Roth RA, Wallberg-Henriksson H & Zierath JR (1999). Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats. Diabetes 48, 664-670.
127. Supinski GS & Callahan LA (2007). Free radical-mediated skeletal muscle dysfunction in inflammatory conditions. J Appl Physiol 102, 2056-2063.
128. Tang K, Wagner PD & Breen EC (2010). TNF-α-mediated reduction in PGC-1α may impair skeletal muscle function after cigarette smoke exposure. J Cell Physiol 222, 320-327.
129. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, Sørensen TI & Lange P (2006). Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 173, 79-83.
130. Vianna LG, Koulouris N, Lanigan C & Moxham J (1990). Effect of acute hypercapnia on limb muscle contractility in humans. J Appl Physiol 69, 1486-1493.
131. Vijayasarathy C, Damle S, Prabu SK, Otto CM & Avadhani NG (2003). Adaptive changes in the expression of nuclear and mitochondrial encoded subunits of cytochrome c oxidase and the catalytic activity during hypoxia. Eur J Biochem 270, 871-879.
132. 2 therapy. J Appl Physiol 81, 2198-2202.
133. Vogiatzis I, Terzis G, Nanas S, Stratakos G, Simoes DC, Georgiadou O, Zakynthinos S & Roussos C (2005). Skeletal muscle adaptations to interval training in patients with advanced COPD. Chest 128, 3838-3845.
134. 2 levels cause mitochondrial dysfunction and impair cell proliferation. J Biol Chem 286, 37067-37076.
135. Wagner PD (2008). Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 31, 492-501.
136. Walker PP, Burnett A, Flavahan PW & Calverley PMA (2008). Lower limb activity and its determinants in COPD. Thorax 63, 683-689.
137. Wang Z, Kontani Y, Sato Y, Mizuno T, Mori N & Yamashita H (2003). Muscle type difference in the regulation of UCP3 under cold conditions. Biochem Biophys Res Commun 305, 244-249.
138. Weber K, Brück P, Mikes Z, Küpper JH, Klingenspor M & Wiesner RJ (2002). Glucocorticoid hormone stimulates mitochondrial biogenesis specifically in skeletal muscle. Endocrinology 143, 177-184.
139. Westerblad H & Allen DG (2011). Emerging roles of ROS/RNS in muscle function and fatigue. Antioxid Redox Signal 15, 2487-2499.
140. Whittom F, Jobin J, Simard PM, Leblanc P, Simard C, Bernard S, Belleau R & Maltais F (1998). Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 30, 1467-1474.
141. Wüst RC, Morse CI, de Haan A, Rittweger J, Jones DA & Degens H (2008). Skeletal muscle properties and fatigue resistance in relation to smoking history. Eur J Appl Physiol 104, 103-110.
142. Yan Z, Okutsu M, Akhtar YN & Lira VA (2011). Regulation of exercise-induced fiber type transformation, mitochondrial biogenesis, and angiogenesis in skeletal muscle. J Appl Physiol 110, 264-274.
143. Yende S, Waterer GW, Tolley EA, Newman AB, Bauer DC, Taaffe DR, Jensen R, Crapo R, Rubin S, Nevitt M, Simonsick EM, Satterfield S, Harris T & Kritchevsky SB (2006). Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 61, 10-16.
144. Yong R & Searcy DG (2001). Sulfide oxidation coupled to ATP synthesis in chicken liver mitochondria. Comp Biochem Physiol B Biochem Mol Biol 129, 129-137.
145. You YN, Short KR, Jourdan M, Klaus KA, Walrand S & Nair KS (2009). The effect of high glucocorticoid administration and food restriction on rodent skeletal muscle mitochondrial function and protein metabolism. PLoS One 4, e5283.
146. Young LJ & Caughey WS (1990). Pathobiochemistry of CO poisoning. FEBS Lett 272, 1-6.
147. Zoll J, N'Guessan B, Ribera F, Lampert E, Fortin D, Veksler V, Bigard X, Geny B, Lonsdorfer J, Ventura-Clapier R & Mettauer B (2003). Preserved response of mitochondrial function to short-term endurance training in skeletal muscle of heart transplant recipients. J Am Coll Cardiol 42, 126-132.
148. Zoll J, Sanchez H, N'Guessan B, Ribera F, Lampert E, Bigard X, Serrurier B, Fortin D, Geny B, Veksler V, Ventura-Clapier R & Mettauer B (2002). Physical activity changes the regulation of mitochondrial respiration in human skeletal muscle. J Physiol 543, 191-200.